Miraculous Medicines

teleport me to a random drug
Minted: - / 5000

2748 Amitifadine
da43d5dadc68b7f9a35cdbae3810a2560756ec57a9fa011c2687b7a377c550cc

This DRUG has not been minted yet.
Mint it now with MetaMask!

Send:
ETH
and donate to medical research.
Note: transaction fees shown in metamask are an approximation and are likely to be smaller.

Properties

Chemistry

Amitifadine (developmental code names DOV-21,947, EB-1010) is a serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) or so-called triple reuptake inhibitor (TRI) which is or was being developed by Euthymics Bioscience It was under development for the treatment of major depressive disorder, but in May 2013, it was reported that the drug failed to show superior efficacy to placebo in a phase IIb/IIIa clinical trial. It was suggested that this may have been due to the drug being underdosed. In September 2017, development of amitifadine for the treatment of major depressive disorder was finally officially discontinued. As of September 2017, it is still listed as being under development for the treatment of alcoholism and smoking withdrawal.

From Wikipedia, the free encyclopedia. License: CC BY-SA.
≪ Previous
2747 Next ≫
2749
Made with on Earth by F. Boffa and T. Calemme
This website does not track you.
Read the contract on Etherscan